Recital 7, Regulation (EU) 2025/2086

In forcesince 17 Oct 2025

Due to the specificities of medical devices, some of the required evidence, such as the evidence to address some research questions of the assessment scope, may only become available after the medical device has been placed on the market. In such instances, where the joint clinical assessment of the medical device has been initiated soon after its certification under Regulation (EU) 2017/745 or Regulation (EU) 2017/746, it should be possible for the Coordination Group to assess the additional evidence by way of initiating the relevant updates of the joint clinical assessment. Joint scientific consultations can also facilitate the process of preparing relevant updates of joint clinical assessment of medical devices when the requests for joint scientific consultation meet the eligibility and selection criteria.